PLoS ONE (Jan 2019)

Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection.

  • Ashley D Smith,
  • Elissa D Foss,
  • Irma Zhang,
  • Jessica L Hastie,
  • Nicole P Giordano,
  • Lusine Gasparyan,
  • Lam Phuc VinhNguyen,
  • Alyxandria M Schubert,
  • Deepika Prasad,
  • Hannah L McMichael,
  • Jinchun Sun,
  • Richard D Beger,
  • Vahan Simonyan,
  • Siobhán C Cowley,
  • Paul E Carlson

DOI
https://doi.org/10.1371/journal.pone.0223025
Journal volume & issue
Vol. 14, no. 9
p. e0223025

Abstract

Read online

Clostridium difficile (Cd) infection (CDI) typically occurs after antibiotic usage perturbs the gut microbiota. Mucosa-associated invariant T cells (MAIT) are found in the gut and their development is dependent on Major histocompatibility complex-related protein 1 (MR1) and the host microbiome. Here we were interested in determining whether the absence of MR1 impacts resistance to CDI. To this end, wild-type (WT) and MR1-/- mice were treated with antibiotics and then infected with Cd spores. Surprisingly, MR1-/- mice exhibited resistance to Cd colonization. 16S rRNA gene sequencing of feces revealed inherent differences in microbial composition. This colonization resistance was transferred from MR1-/- to WT mice via fecal microbiota transplantation, suggesting that MR1-dependent factors influence the microbiota, leading to CDI susceptibility.